Literature DB >> 22843489

Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method.

Jing Shi, Annemiek Willemze, George M C Janssen, Peter A van Veelen, Jan Wouter Drijfhout, Anthony Cerami, Tom W J Huizinga, Leendert A Trouw, René E Toes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843489     DOI: 10.1136/annrheumdis-2012-201559

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  35 in total

1.  Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.

Authors:  Alvin Yee; Tyler Webb; Andrea Seaman; Maria Infantino; Francesca Meacci; Mariangela Manfredi; Maurizio Benucci; Gabriella Lakos; Ennio Favalli; Tommaso Schioppo; Tommaso Shioppo; Pier-Luigi Meroni; Michael Mahler
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.

Authors:  Emilio Martin-Mola; Alejandro Balsa; Rosario García-Vicuna; Juan Gómez-Reino; Miguel Angel González-Gay; Raimon Sanmartí; Estíbaliz Loza
Journal:  Rheumatol Int       Date:  2016-06-06       Impact factor: 2.631

Review 3.  Autoantibody-mediated bone loss.

Authors:  Ulrike Harre; Nicolai A Kittan; Georg Schett
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

Review 4.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 5.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

6.  Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.

Authors:  Ryan W Gan; Leendert A Trouw; Jing Shi; René E M Toes; Tom W J Huizinga; M Kristen Demoruelle; Jason R Kolfenbach; Gary O Zerbe; Kevin D Deane; Jess D Edison; William R Gilliland; Jill M Norris; V Michael Holers
Journal:  J Rheumatol       Date:  2015-01-15       Impact factor: 4.666

7.  Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.

Authors:  Gregory J Challener; Jonathan D Jones; Adam J Pelzek; B JoNell Hamilton; Gilles Boire; Artur José de Brum-Fernandes; Ariel Masetto; Nathalie Carrier; Henri A Ménard; Gregg J Silverman; William F C Rigby
Journal:  J Rheumatol       Date:  2015-12-15       Impact factor: 4.666

Review 8.  Insights into the study and origin of the citrullinome in rheumatoid arthritis.

Authors:  Justyna Fert-Bober; Erika Darrah; Felipe Andrade
Journal:  Immunol Rev       Date:  2019-12-25       Impact factor: 12.988

Review 9.  The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA.

Authors:  Annie Yarwood; Tom W J Huizinga; Jane Worthington
Journal:  Rheumatology (Oxford)       Date:  2014-09-18       Impact factor: 7.580

Review 10.  Cytokines as biomarkers in rheumatoid arthritis.

Authors:  Agata Burska; Marjorie Boissinot; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.